The Society of Nuclear Medicine and Molecular Imaging (SNMMI), Us TOO and the Prostate Cancer Research Institute (PCRI) will offer a free 1-day conference on July 26, 2014, in Chicago, Ill., to educate patients about new nuclear medicine therapies and tracers that can help treat prostate cancer.

The program offers a full day of sessions including in-depth discussions surrounding targeted biopsies and focal therapy, PET scan trends, and new tests for prostate cancer risk and aggressiveness. Speakers will include industry thought leaders from local institutions such as Northwestern University and the University of Chicago, as well as Bayer Healthcare and Cancer Treatment Centers of America.

Registration is FREE, but registration is required.